Skip to content
Parakho

Entero Healthcare Solutions Ltd

NSE ENTEROBSE 544122enterohealthcare.com

Q1 FY27, unaudited

Revenue
₹1,940.50 Cr
Profit after tax
₹52.05 Cr

As filed with the exchange, consolidated basis.

Statement of profit and loss

Figures in ₹ crore, reproduced from the results data files the company filed with NSE under Regulation 33 of the SEBI (LODR) Regulations. Nothing is restated, adjusted or estimated.

Statement of profit and loss, consolidated basis
₹ croreQ1 FY27vs a year agoFY26
Revenue from operations1,940.50+38.23%6,591.21
Other income3.01−48.38%19.24
Total income1,943.50+37.87%6,610.45
Employee benefit expense69.42+20.60%245.50
Finance costs20.57+92.91%54.39
Depreciation & amortisation12.31+38.74%43.29
Total expenses1,876.38+36.63%6,422.94
Profit before tax67.12+84.58%179.34
Tax expense15.07+145.78%33.50
Profit after tax52.05+72.17%145.84
Total comprehensive income51.92+71.05%145.25
Earnings per share
Earnings per share, basic₹8.77₹26.44
Earnings per share, diluted₹8.76₹26.40

Q1 FY27 — unaudited, from the company’s filing with NSE. Source

Q1 FY26, the year-ago base — unaudited, from the company’s filing with NSE. Source

FY26 — from the company’s filing with NSE. Source

Earnings call

Q4 FY26

Entero Healthcare Solutions reported full year FY26 revenue of Rs 6,591 crores, growing 31.5% year-on-year on a like-for-like basis, with EBITDA margin of 4% and PAT of Rs 146 crores. Quarter 4 revenue grew 42.6% year-on-year with EBITDA margin at 4.5% and PAT growing 44% to Rs 45.1 crores. Management gave FY27 guidance of 23% revenue growth excluding new acquisitions, 5% EBITDA margin, and at least 50% EBITDA to operating cash flow conversion.

Generated by AI from the filed transcript; every statement on the full page carries its verbatim quote. Read the cited summary

Filings

12 shown · 52 published by the exchange

BSE corporate announcements, classified by Parakho. The exchange’s own category is kept alongside our classification so a reclassification never rewrites history.

Page generated from filings held to 24 Aug 2026.